SARAH JOHNSON: Open Payments
NPI 1447998505 · NATCHITOCHES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $183 |
| Medtronic, Inc. | 2 | $125 |
| Supernus Pharmaceuticals, Inc. | 2 | $80 |
| ABBVIE INC. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Auvelity, Qelbree, UNID_PASS, CD HORIZON SPINAL SYSTEM, VRAYLAR, CAPLYTA, TRINTELLIX, REXULTI.
Industry payments across LA — which companies pay providers there.
